MBX Biosciences (MBX) Institutional Ownership $20.36 +0.09 (+0.44%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$384.09MNumber ofInstitutional Sellers(last 12 months)0 Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBX Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now MBX Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.450,000$11.69M0.0%N/A1.346% 11/19/2024 Barclays PLC16,400$426K0.0%N/A0.049% 11/18/2024 Teachers Retirement System of The State of Kentucky26,708$694K0.0%N/A0.080% 11/16/2024 Geode Capital Management LLC22,269$579K0.0%N/A0.067% 11/15/2024 Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909% 11/15/2024 Barclays PLC16,400$426K0.0%N/A0.049% 11/15/2024 Jane Street Group LLC26,570$690K0.0%N/A0.080% 11/15/2024 Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791% 11/15/2024 Soros Fund Management LLC30,000$779K0.0%N/A0.090% 11/15/2024 RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522% 11/15/2024 Point72 DIFC Ltd24,011$624K0.0%N/A0.072% 11/15/2024 Point72 Asset Management L.P.15,600$405K0.0%N/A0.047% 11/15/2024 Maven Securities LTD50,000$1.30M0.0%N/A0.150% 11/15/2024 Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032% 11/14/2024 NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816% 11/13/2024 The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138% (Data available from 1/1/2016 forward) MBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBX shares? During the previous two years, 15 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($155.50M), NEA Management Company LLC ($93.90M), Wellington Management Group LLP ($74.26M), RA Capital Management L.P. ($39.26M), Franklin Resources Inc. ($11.69M), Maven Securities LTD ($1.30M), and The Manufacturers Life Insurance Company ($1.20M).Learn more on MBX's institutional investors. Which institutional investors have been buying MBX Biosciences stock? Of the 15 institutional investors that purchased MBX Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), Franklin Resources Inc. ($450K), Maven Securities LTD ($50K), and The Manufacturers Life Insurance Company ($46.19K). How much institutional buying is happening at MBX Biosciences? Institutional investors have bought a total of 14,783,878 shares in the last 24 months. This purchase volume represents approximately $384.09M in transactions. Related Companies Agios Pharmaceuticals Institutional Ownership Protagonist Therapeutics Institutional Ownership Amneal Pharmaceuticals Institutional Ownership Longboard Pharmaceuticals Institutional Ownership Ligand Pharmaceuticals Institutional Ownership Geron Institutional Ownership NewAmsterdam Pharma Institutional Ownership IDEAYA Biosciences Institutional Ownership Centessa Pharmaceuticals Institutional Ownership Wave Life Sciences Institutional Ownership This page (NYSE:MBX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
